Phase II Clinical Trial Evaluating the Efficacy and Safety of HRS-7249 and SHR-1918 in Patients With Severe Hypertriglyceridemia at High Risk of Acute Pancreatitis

Clinical trial NCT07308392 · RECRUITING

Trial details

NCT number: NCT07308392
Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Severe Hypertriglyceridemia With a High Risk of Acute Pancreatitis

Start date: 2026-02-25
Primary completion: 2027-06-01
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.